Tuberculosis treatment loss to follow-up in children exposed at home: A prospective cohort study.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
16 Aug 2024
Historique:
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

Loss to follow-up (LTFU) from tuberculosis (TB) treatment and care is a significant public health problem. It is important to understand what drives LTFU in children - a population whose treatment and management depend on an adult caregiver - to better provide support services to families affected by TB. We conducted a prospective cohort study of household contacts in Lima, Peru (2009-12). Using multilevel logistic regression analysis, we explored individual-level characteristics of children and their adult household members with TB disease to identify risk factors for LTFU among children initiated on treatment for TB. A total of 154 child (0-14 years) household contacts were diagnosed with TB and initiated on treatment. While most (n = 133, 86.4%) had a successful outcome, 20 (13.0%) children were LTFU. Six (30.0%) children were LTFU within three months, nine (45.0%) between five to seven months, and three (15.0%) after seven months of treatment being initiated. In univariable analysis, children with index patients above 25 years of age had decreased odds of being LTFU (odds ratio = 0.26; 95% confidence interval = 0.08-0.84) compared to children with index patients 25 years or younger. In this cohort, more than 10% of children sick with TB who were exposed to the disease at home were LTFU. An integrated, family-centred TB prevention and management approach may reduce barriers to a child completing their course of TB treatment.

Sections du résumé

Background UNASSIGNED
Loss to follow-up (LTFU) from tuberculosis (TB) treatment and care is a significant public health problem. It is important to understand what drives LTFU in children - a population whose treatment and management depend on an adult caregiver - to better provide support services to families affected by TB.
Methods UNASSIGNED
We conducted a prospective cohort study of household contacts in Lima, Peru (2009-12). Using multilevel logistic regression analysis, we explored individual-level characteristics of children and their adult household members with TB disease to identify risk factors for LTFU among children initiated on treatment for TB.
Results UNASSIGNED
A total of 154 child (0-14 years) household contacts were diagnosed with TB and initiated on treatment. While most (n = 133, 86.4%) had a successful outcome, 20 (13.0%) children were LTFU. Six (30.0%) children were LTFU within three months, nine (45.0%) between five to seven months, and three (15.0%) after seven months of treatment being initiated. In univariable analysis, children with index patients above 25 years of age had decreased odds of being LTFU (odds ratio = 0.26; 95% confidence interval = 0.08-0.84) compared to children with index patients 25 years or younger.
Conclusions UNASSIGNED
In this cohort, more than 10% of children sick with TB who were exposed to the disease at home were LTFU. An integrated, family-centred TB prevention and management approach may reduce barriers to a child completing their course of TB treatment.

Identifiants

pubmed: 39149829
doi: 10.7189/jogh.14.04194
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04194

Informations de copyright

Copyright © 2024 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.

Auteurs

Meredith B Brooks (MB)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Brittney J van de Water (BJ)

Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA.

Leonid Lecca (L)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Partners In Health / Socios En Salud, Lima, Peru.

Chuan-Chin Huang (CC)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Brigham and Women's Hospital, Boston, Massachusetts, USA.

Letizia Trevisi (L)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Carmen Contreras (C)

Partners In Health / Socios En Salud, Lima, Peru.

Jerome T Galea (JT)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
School of Social Work, University of South Florida, Tampa, Florida, USA.

Roger Calderon (R)

Partners In Health / Socios En Salud, Lima, Peru.

Rosa Yataco (R)

Partners In Health / Socios En Salud, Lima, Peru.

Megan Murray (M)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Partners In Health / Socios En Salud, Lima, Peru.

Mercedes C Becerra (MC)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Partners In Health / Socios En Salud, Lima, Peru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH